Phase II Trial for Large ER-Negative Breast Cancers

NCT01869192 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

72

Enrollment

OTHER

Sponsor class

Conditions

Malignant Neoplasm of Female Breast

Interventions

DRUG: Epirubicin
DRUG: Cyclophosphamide
DRUG: Docetaxel
DRUG: Capecitabine
RADIATION: Radiation Therapy

Sponsor

University of Colorado, Denver